Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.4 replaces the previous v3.6.3. This signals a minor platform update that does not modify the study information displayed on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now displays Revision: v3.6.3, indicating the study record has been updated to the latest revision. This change reflects a metadata revision on the page rather than an update to the substantive study information.SummaryDifference0.1%

- Check34 days agoChange DetectedThe revision label changed from v3.6.0 to v3.6.2, indicating a minor page/system update.SummaryDifference0.1%

- Check48 days agoChange DetectedRecruitment status was updated to No longer looking for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The label for Intervention/Treatment was standardized and the revision/version label updated to v3.6.0.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a small backend/content management system update to this page. This update does not change the visible content or the information presented about the study.SummaryDifference0.1%

- Check62 days agoChange DetectedThe results status changed from 'No Results Posted' to 'Results Submitted', indicating that outcome data are being submitted for posting and will be available after processing.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.